Related references
Note: Only part of the references are listed.Proteasome inhibitors: possible novel therapeutic strategy for ischemia-reperfusion injury?
Apostolos N. Kandilis et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Molecular Basis of NF-kappa B Signaling
Johanna Napetschnig et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 42 (2013)
Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells
Xiucheng Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
The novel proteasome inhibitor carfilzomib induces cell cycle arrest, apoptosis and potentiates the anti-tumour activity of chemotherapy in rituximab-resistant lymphoma
Juan J. Gu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Effect of hOGG1 Over-Expression on Cisplatin Resistance in Esophageal Squamous Carcinoma Cells
Daqing Gao et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
Ubiquitin-Proteasome Pathway and Prostate Cancer
Fang-Zhi Chen et al.
ONKOLOGIE (2013)
Inhibition of the PI3K/Akt/GSK3 Pathway Downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD Downregulates DNA Damage-Induced Chk1 Activation as Well as G2/M Arrest and Prominently Enhances Induction of Apoptosis
Tetsuya Kurosu et al.
PLOS ONE (2013)
A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma
Yi-Fu He et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma
Yan Shi et al.
ONCOTARGETS AND THERAPY (2013)
Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone
V. Khedgikar et al.
CELL DEATH & DISEASE (2013)
Proteasome inhibition leads to altered signaling in the proteome of cisplatin-resistant human ovarian carcinoma cell line
J. Duraj et al.
NEOPLASMA (2013)
Proteasome Inhibitor Interacts Synergistically With Autophagy Inhibitor to Suppress Proliferation and Induce Apoptosis in Hepatocellular Carcinoma
Bo Hui et al.
CANCER (2012)
The ubiquitin proteasome system and efficacy of proteasome inhibitors in diseases
Selvarajan Chitra et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2012)
Antitumor Effects of Proteasome Inhibition in Anaplastic Thyroid Carcinoma
Annette Altmann et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer A Phase-II Study of The SWOG (S0414)
Michael B. Tomblyn et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Therapeutic targeting of cancer cell cycle using proteasome inhibitors
Namrata Rastogi et al.
CELL DIVISION (2012)
THERAPEUTICS Opening the door to a new class of proteasome inhibitors
Alexandra Flemming
NATURE REVIEWS CANCER (2012)
Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention
H. Yang et al.
CURRENT CANCER DRUG TARGETS (2011)
Aging and calorie restriction modulate yeast redox state, oxidized protein removal, and the ubiquitin-proteasome system
Fernanda Marques da Cunha et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Follicular Thyroid Cancer Cell Growth Inhibition By Proteosome Inhibitor MG132
Samantha J. Stoll et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Proteasome inhibitor PS-341 induces apoptosis in cisplatin-resistant squamous cell carcinoma cells by induction of Noxa
Andrew M. Fribley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Proteasome inhibitor PS-341 induces a apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells
A Fribley et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Share Paper
